After Mint’s misleading reporting, Patent Circle has decided not to report anymore about granted pharmaceutical patents in India. Some of our readers has humbly suggested that it would be in better interest that Patent Circle must stop tracking and reporting on granted pharmaceutical patents in India and should focus writing more on general topics and various aspect of India patent laws. We sincerely appreciate our readers’ suggestion and will definitely stay away from reporting on Indian patents.
Hey Varun this is most miserable part of our system that people without any familiarity or experience in patent practice and pharma patents are writing/blogging anything about patents. Back in the US, even experienced patent attorneys pause making strong statements. BTW how is your work going on? Better you keep focus on professional commitments.
ReplyDelete